{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:22:53Z","timestamp":1774524173558,"version":"3.50.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T00:00:00Z","timestamp":1447977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s11011-015-9768-8","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T18:32:56Z","timestamp":1458325976000},"page":"377-383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Intracerebroventricular administration of \u03b1-ketoisocaproic acid decreases brain-derived neurotrophic factor and nerve growth factor levels in brain of young rats"],"prefix":"10.1007","volume":"31","author":[{"given":"Miriam S. W.","family":"Wisniewski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Carvalho-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara M.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo G.","family":"Zapelini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia F.","family":"Schuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo C.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giselli","family":"Scaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio L.","family":"Streck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,20]]},"reference":[{"key":"9768_CR1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2010.02.018","volume":"1324","author":"AU Amaral","year":"2010","unstructured":"Amaral AU, Leipnitz G, Fernandes CG, Seminotti B, Schuck PF, Wajner M (2010) Alpha-ketoisocaproic acid and leucine provoke mitochondrial bioenergetic dysfunction in rat brain. Brain Res 1324:75\u201384. doi: 10.1016\/j.brainres.2010.02.018","journal-title":"Brain Res"},{"key":"9768_CR2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0197-0186(00)00100-5","volume":"38","author":"P Araujo","year":"2001","unstructured":"Araujo P et al. (2001) Reduction of large neutral amino acid levels in plasma and brain of hyperleucinemic rats. Neurochem Int 38:529\u2013537","journal-title":"Neurochem Int"},{"key":"9768_CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11011-007-9077-y","volume":"23","author":"AG Barschak","year":"2008","unstructured":"Barschak AG, Sitta A, Deon M, Barden AT, Dutra-Filho CS, Wajner M, Vargas CR (2008) Oxidative stress in plasma from maple syrup urine disease patients during treatment. Metab Brain Dis 23:71\u201380. doi: 10.1007\/s11011-007-9077-y","journal-title":"Metab Brain Dis"},{"key":"9768_CR4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.clinbiochem.2008.12.005","volume":"42","author":"AG Barschak","year":"2009","unstructured":"Barschak AG et al. (2009) Amino acids levels and lipid peroxidation in maple syrup urine disease patients. Clin Biochem 42:462\u2013466. doi: 10.1016\/j.clinbiochem.2008.12.005","journal-title":"Clin Biochem"},{"key":"9768_CR5","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.neurobiolaging.2013.08.029","volume":"35","author":"JC Belrose","year":"2014","unstructured":"Belrose JC, Masoudi R, Michalski B, Fahnestock M (2014) Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies. Neurobiol Aging 35:926\u2013933. doi: 10.1016\/j.neurobiolaging.2013.08.029","journal-title":"Neurobiol Aging"},{"key":"9768_CR6","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1101\/gad.841400","volume":"14","author":"M Bibel","year":"2000","unstructured":"Bibel M, Barde YA (2000) Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 14:2919\u20132937","journal-title":"Genes Dev"},{"key":"9768_CR7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11011-005-4152-8","volume":"20","author":"R Bridi","year":"2005","unstructured":"Bridi R, Braun CA, Zorzi GK, Wannmacher CM, Wajner M, Lissi EG, Dutra-Filho CS (2005) alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats. Metab Brain Dis 20:155\u2013167","journal-title":"Metab Brain Dis"},{"key":"9768_CR8","doi-asserted-by":"crossref","first-page":"13279","DOI":"10.1073\/pnas.94.24.13279","volume":"94","author":"M Canossa","year":"1997","unstructured":"Canossa M, Griesbeck O, Berninger B, Campana G, Kolbeck R, Thoenen H (1997) Neurotrophin release by neurotrophins: implications for activity-dependent neuronal plasticity. Proc Natl Acad Sci U S A 94:13279\u201313286","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9768_CR9","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/emboj\/20.7.1640","volume":"20","author":"M Canossa","year":"2001","unstructured":"Canossa M, Gartner A, Campana G, Inagaki N, Thoenen H (2001) Regulated secretion of neurotrophins by metabotropic glutamate group I (mGluRI) and Trk receptor activation is mediated via phospholipase C signalling pathways. The EMBO journal 20:1640\u20131650. doi: 10.1093\/emboj\/20.7.1640","journal-title":"The EMBO journal"},{"key":"9768_CR10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/mcne.1997.0641","volume":"9","author":"A Cellerino","year":"1997","unstructured":"Cellerino A, Carroll P, Thoenen H, Barde YA (1997) Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor. Mol Cell Neurosci 9:397\u2013408. doi: 10.1006\/mcne.1997.0641","journal-title":"Mol Cell Neurosci"},{"key":"9768_CR11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuron.2004.06.024","volume":"43","author":"JR Chan","year":"2004","unstructured":"Chan JR et al. (2004) NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron 43:183\u2013191. doi: 10.1016\/j.neuron.2004.06.024","journal-title":"Neuron"},{"key":"9768_CR12","first-page":"1971","volume-title":"The metabolic and molecular bases of inherited disease","author":"DT Chuang","year":"2001","unstructured":"Chuang DT, Shih VE (2001) Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp. 1971\u20132005"},{"key":"9768_CR13","first-page":"1971","volume-title":"The metabolic and molecular bases of inherited disease","author":"DT Chuang","year":"2008","unstructured":"Chuang DT, Wynn M, Shih VE (2008) Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver CR, Beaudet AL, Sly WL, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp. 1971\u20132005"},{"key":"9768_CR14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pbb.2003.10.013","volume":"77","author":"Vasques V Castro de","year":"2004","unstructured":"de Castro VV, de Boer MA, Diligenti F, Brinco F, Mallmann F, Mello CF, Wajner M (2004) Intrahippocampal administration of the alpha-keto acids accumulating in maple syrup urine disease provokes learning deficits in rats. Pharmacol Biochem Behav 77:183\u2013190","journal-title":"Pharmacol Biochem Behav"},{"key":"9768_CR15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.mcn.2005.11.001","volume":"31","author":"Y Du","year":"2006","unstructured":"Du Y, Fischer TZ, Clinton-Luke P, Lercher LD, Dreyfus CF (2006) Distinct effects of p75 in mediating actions of neurotrophins on basal forebrain oligodendrocytes. Mol Cell Neurosci 31:366\u2013375. doi: 10.1016\/j.mcn.2005.11.001","journal-title":"Mol Cell Neurosci"},{"key":"9768_CR16","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1046\/j.1471-4159.2002.01030.x","volume":"82","author":"D Garzon","year":"2002","unstructured":"Garzon D, Yu G, Fahnestock M (2002) A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex. J Neurochem 82:1058\u20131064","journal-title":"J Neurochem"},{"key":"9768_CR17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3233\/JAD-2011-110047","volume":"25","author":"F Gelfo","year":"2011","unstructured":"Gelfo F, Tirassa P, De Bartolo P, Caltagirone C, Petrosini L, Angelucci F (2011) Brain and serum levels of nerve growth factor in a rat model of Alzheimer's disease. J Alzheimer's disease : JAD 25:213\u2013217. doi: 10.3233\/JAD-2011-110047","journal-title":"J Alzheimer's disease : JAD"},{"key":"9768_CR18","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s10571-010-9538-4","volume":"30","author":"V Glaser","year":"2010","unstructured":"Glaser V et al. (2010) The intra-hippocampal leucine administration impairs memory consolidation and LTP generation in rats. Cell Mol Neurobiol 30:1067\u20131075. doi: 10.1007\/s10571-010-9538-4","journal-title":"Cell Mol Neurobiol"},{"key":"9768_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0165-3806(83)90107-4","volume":"285","author":"H Gnahn","year":"1983","unstructured":"Gnahn H, Hefti F, Heumann R, Schwab ME, Thoenen H (1983) NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain? Brain Res 285:45\u201352","journal-title":"Brain Res"},{"key":"9768_CR20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neulet.2009.02.027","volume":"453","author":"H Gu","year":"2009","unstructured":"Gu H, Long D, Song C, Li X (2009) Recombinant human NGF-loaded microspheres promote survival of basal forebrain cholinergic neurons and improve memory impairments of spatial learning in the rat model of Alzheimer's disease with fimbria-fornix lesion. Neurosci Lett 453:204\u2013209. doi: 10.1016\/j.neulet.2009.02.027","journal-title":"Neurosci Lett"},{"key":"9768_CR21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/sj.bjp.0704467","volume":"135","author":"JJ Haddad","year":"2002","unstructured":"Haddad JJ, Land SC (2002) Redox\/ROS regulation of lipopolysaccharide-induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-alpha biosynthesis. Br J Pharmacol 135:520\u2013536. doi: 10.1038\/sj.bjp.0704467","journal-title":"Br J Pharmacol"},{"key":"9768_CR22","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/archneur.57.6.846","volume":"57","author":"C Hock","year":"2000","unstructured":"Hock C, Heese K, Hulette C, Rosenberg C, Otten U (2000) Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 57:846\u2013851","journal-title":"Arch Neurol"},{"key":"9768_CR23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3181\/00379727-113-28456","volume":"113","author":"RK Howell","year":"1963","unstructured":"Howell RK, Lee M (1963) Influence of alpha-ketoacids on the respiration of brain in vitro. Proc Soc Exp Biol Med 113:660\u2013663","journal-title":"Proc Soc Exp Biol Med"},{"key":"9768_CR24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","volume":"24","author":"EJ Huang","year":"2001","unstructured":"Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677\u2013736. doi: 10.1146\/annurev.neuro.24.1.677","journal-title":"Annu Rev Neurosci"},{"key":"9768_CR25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0169-328X(97)00190-3","volume":"50","author":"E Iwata","year":"1997","unstructured":"Iwata E, Asanuma M, Nishibayashi S, Kondo Y, Ogawa N (1997) Different effects of oxidative stress on activation of transcription factors in primary cultured rat neuronal and glial cells Brain research. Mol Brain Res 50:213\u2013220","journal-title":"Mol Brain Res"},{"key":"9768_CR26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00234-003-0955-7","volume":"45","author":"W Jan","year":"2003","unstructured":"Jan W, Zimmerman RA, Wang ZJ, Berry GT, Kaplan PB, Kaye EM (2003) MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology 45:393\u2013399. doi: 10.1007\/s00234-003-0955-7","journal-title":"Neuroradiology"},{"key":"9768_CR27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1017\/S1740925X09000052","volume":"4","author":"YY Jean","year":"2008","unstructured":"Jean YY, Lercher LD, Dreyfus CF (2008) Glutamate elicits release of BDNF from basal forebrain astrocytes in a process dependent on metabotropic receptors and the PLC pathway. Neuron Glia Biol 4:35\u201342. doi: 10.1017\/S1740925X09000052","journal-title":"Neuron Glia Biol"},{"key":"9768_CR28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1749-6632.2000.tb05604.x","volume":"926","author":"P Jouvet","year":"2000","unstructured":"Jouvet P, Kozma M, Mehmet H (2000a) Primary human fibroblasts from a maple syrup urine disease patient undergo apoptosis following exposure to physiological concentrations of branched chain amino acids. Ann N Y Acad Sci 926:116\u2013121","journal-title":"Ann N Y Acad Sci"},{"key":"9768_CR29","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1091\/mbc.11.5.1919","volume":"11","author":"P Jouvet","year":"2000","unstructured":"Jouvet P et al. (2000b) Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 11:1919\u20131932","journal-title":"Mol Biol Cell"},{"key":"9768_CR30","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10545-012-9582-y","volume":"36","author":"D Klee","year":"2013","unstructured":"Klee D et al. (2013) Structural white matter changes in adolescents and young adults with maple syrup urine disease. J Inherit Metab Dis 36:945\u2013953. doi: 10.1007\/s10545-012-9582-y","journal-title":"J Inherit Metab Dis"},{"key":"9768_CR31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0006-8993(00)02634-2","volume":"875","author":"RL Klein","year":"2000","unstructured":"Klein RL, Hirko AC, Meyers CA, Grimes JR, Muzyczka N, Meyer EM (2000) NGF gene transfer to intrinsic basal forebrain neurons increases cholinergic cell size and protects from age-related, spatial memory deficits in middle-aged rats. Brain Res 875:144\u2013151","journal-title":"Brain Res"},{"key":"9768_CR32","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1126\/science.1065057","volume":"294","author":"R Lee","year":"2001","unstructured":"Lee R, Kermani P, Teng KK, Hempstead BL (2001) Regulation of cell survival by secreted proneurotrophins. Science 294:1945\u20131948. doi: 10.1126\/science.1065057","journal-title":"Science"},{"key":"9768_CR33","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.neurobiolaging.2003.09.003","volume":"24","author":"KC Lim","year":"2003","unstructured":"Lim KC, Lim ST, Federoff HJ (2003) Neurotrophin secretory pathways and synaptic plasticity. Neurobiol Aging 24:1135\u20131145","journal-title":"Neurobiol Aging"},{"key":"9768_CR34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"9768_CR35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrn1726","volume":"6","author":"B Lu","year":"2005","unstructured":"Lu B, Pang PT, Woo NH (2005) The yin and yang of neurotrophin action. Nat Rev Neurosci 6:603\u2013614. doi: 10.1038\/nrn1726","journal-title":"Nat Rev Neurosci"},{"key":"9768_CR36","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nlm.2007.08.018","volume":"89","author":"Y Lu","year":"2008","unstructured":"Lu Y, Christian K, Lu B (2008) BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory? Neurobiol Learn Mem 89:312\u2013323. doi: 10.1016\/j.nlm.2007.08.018","journal-title":"Neurobiol Learn Mem"},{"key":"9768_CR37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0166-2236(92)90047-C","volume":"15","author":"SO Meakin","year":"1992","unstructured":"Meakin SO, Shooter EM (1992) The nerve growth factor family of receptors. Trends Neurosci 15:323\u2013331","journal-title":"Trends Neurosci"},{"key":"9768_CR38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1469-7793.2001.0091b.x","volume":"533","author":"LM Mendell","year":"2001","unstructured":"Mendell LM, Munson JB, Arvanian VL (2001) Neurotrophins and synaptic plasticity in the mammalian spinal cord. J Physiol 533:91\u201397","journal-title":"J Physiol"},{"key":"9768_CR39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11011-011-9238-x","volume":"26","author":"C Mescka","year":"2011","unstructured":"Mescka C et al. (2011) In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease. Metab Brain Dis 26:21\u201328. doi: 10.1007\/s11011-011-9238-x","journal-title":"Metab Brain Dis"},{"key":"9768_CR40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijdevneu.2012.10.109","volume":"31","author":"CP Mescka","year":"2013","unstructured":"Mescka CP et al. (2013) Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect. Int J Dev Neurosci 31:21\u201324. doi: 10.1016\/j.ijdevneu.2012.10.109","journal-title":"Int J Dev Neurosci"},{"key":"9768_CR41","doi-asserted-by":"crossref","first-page":"8476","DOI":"10.1523\/JNEUROSCI.17-21-08476.1997","volume":"17","author":"GJ Michael","year":"1997","unstructured":"Michael GJ, Averill S, Nitkunan A, Rattray M, Bennett DL, Yan Q, Priestley JV (1997) Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci Off J Soc Neurosci 17:8476\u20138490","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"9768_CR42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0006-8993(99)01592-9","volume":"835","author":"JS Mu","year":"1999","unstructured":"Mu JS, Li WP, Yao ZB, Zhou XF (1999) Deprivation of endogenous brain-derived neurotrophic factor results in impairment of spatial learning and memory in adult rats. Brain Res 835:259\u2013265","journal-title":"Brain Res"},{"key":"9768_CR43","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archneur.60.8.1143","volume":"60","author":"EJ Mufson","year":"2003","unstructured":"Mufson EJ et al. (2003) Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Arch Neurol 60:1143\u20131148. doi: 10.1001\/archneur.60.8.1143","journal-title":"Arch Neurol"},{"key":"9768_CR44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0301-0082(00)00014-9","volume":"63","author":"MG Murer","year":"2001","unstructured":"Murer MG, Yan Q, Raisman-Vozari R (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 63:71\u2013124","journal-title":"Prog Neurobiol"},{"key":"9768_CR45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.expneurol.2008.10.004","volume":"215","author":"AH Nagahara","year":"2009","unstructured":"Nagahara AH et al. (2009) Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery. Exp Neurol 215:153\u2013159. doi: 10.1016\/j.expneurol.2008.10.004","journal-title":"Exp Neurol"},{"key":"9768_CR46","volume-title":"The Rat Brain in Stereotaxic Coordinates vol 2","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C (1986) The Rat Brain in Stereotaxic Coordinates vol 2. Academic Press, San Diego"},{"key":"9768_CR47","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/jnen\/63.6.641","volume":"63","author":"S Peng","year":"2004","unstructured":"Peng S, Wuu J, Mufson EJ, Fahnestock M (2004) Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol 63:641\u2013649","journal-title":"J Neuropathol Exp Neurol"},{"key":"9768_CR48","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1471-4159.2005.03135.x","volume":"93","author":"S Peng","year":"2005","unstructured":"Peng S, Wuu J, Mufson EJ, Fahnestock M (2005) Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem 93:1412\u20131421. doi: 10.1111\/j.1471-4159.2005.03135.x","journal-title":"J Neurochem"},{"key":"9768_CR49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068722","volume":"8","author":"T Rantamaki","year":"2013","unstructured":"Rantamaki T et al. (2013) The impact of Bdnf gene deficiency to the memory impairment and brain pathology of APPswe\/PS1dE9 mouse model of Alzheimer's disease. PLoS One 8:e68722. doi: 10.1371\/journal.pone.0068722","journal-title":"PLoS One"},{"key":"9768_CR50","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1098\/rstb.2006.1894","volume":"361","author":"LF Reichardt","year":"2006","unstructured":"Reichardt LF (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond Ser B Biol Sci 361:1545\u20131564. doi: 10.1098\/rstb.2006.1894","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"9768_CR51","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11064-007-9423-9","volume":"33","author":"CA Ribeiro","year":"2008","unstructured":"Ribeiro CA et al. (2008) Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease. Neurochem Res 33:114\u2013124. doi: 10.1007\/s11064-007-9423-9","journal-title":"Neurochem Res"},{"key":"9768_CR52","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12035-012-8243-3","volume":"45","author":"G Scaini","year":"2012","unstructured":"Scaini G et al. (2012a) Evaluation of acetylcholinesterase in an animal model of maple syrup urine disease. Mol Neurobiol 45:279\u2013286. doi: 10.1007\/s12035-012-8243-3","journal-title":"Mol Neurobiol"},{"key":"9768_CR53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ymgme.2012.04.009","volume":"106","author":"G Scaini","year":"2012","unstructured":"Scaini G et al. (2012b) DNA damage in an animal model of maple syrup urine disease. Mol Genet Metab 106:169\u2013174. doi: 10.1016\/j.ymgme.2012.04.009","journal-title":"Mol Genet Metab"},{"key":"9768_CR54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbr.2012.03.004","volume":"231","author":"G Scaini","year":"2012","unstructured":"Scaini G et al. (2012c) Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease. Behav Brain Res 231:92\u201396. doi: 10.1016\/j.bbr.2012.03.004","journal-title":"Behav Brain Res"},{"key":"9768_CR55","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s10545-012-9549-z","volume":"36","author":"G Scaini","year":"2013","unstructured":"Scaini G et al. (2013a) Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model. J Inherit Metab Dis 36:721\u2013730. doi: 10.1007\/s10545-012-9549-z","journal-title":"J Inherit Metab Dis"},{"key":"9768_CR56","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s12035-013-8447-1","volume":"48","author":"G Scaini","year":"2013","unstructured":"Scaini G et al. (2013b) Acute and chronic administration of the branched-chain amino acids decreases nerve growth factor in rat hippocampus. Mol Neurobiol 48:581\u2013589. doi: 10.1007\/s12035-013-8447-1","journal-title":"Mol Neurobiol"},{"key":"9768_CR57","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s11064-015-1541-1","volume":"40","author":"G Scaini","year":"2015","unstructured":"Scaini G et al. (2015) Acute Administration of Branched-Chain Amino Acids Increases the Pro-BDNF\/Total-BDNF Ratio in the Rat Brain. Neurochem Res 40:885\u2013893. doi: 10.1007\/s11064-015-1541-1","journal-title":"Neurochem Res"},{"key":"9768_CR58","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymgme.2004.01.016","volume":"82","author":"S Schonberger","year":"2004","unstructured":"Schonberger S, Schweiger B, Schwahn B, Schwarz M, Wendel U (2004) Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82:69\u201375. doi: 10.1016\/j.ymgme.2004.01.016","journal-title":"Mol Genet Metab"},{"key":"9768_CR59","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbadis.2003.09.010","volume":"1639","author":"AM Sgaravatti","year":"2003","unstructured":"Sgaravatti AM et al. (2003) Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease. Biochim Biophys Acta 1639:232\u2013238","journal-title":"Biochim Biophys Acta"},{"key":"9768_CR60","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1542\/peds.34.4.454","volume":"34","author":"SE Snyderman","year":"1964","unstructured":"Snyderman SE, Norton PM, Roitman E, Holt LE, Jr. (1964) Maple Syrup Urine Disease, with Particular Reference to Dietotherapy. Pediatrics 34:454\u2013472","journal-title":"Pediatrics"},{"key":"9768_CR61","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","volume":"24","author":"MV Sofroniew","year":"2001","unstructured":"Sofroniew MV, Howe CL, Mobley WC (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24:1217\u20131281. doi: 10.1146\/annurev.neuro.24.1.1217","journal-title":"Annu Rev Neurosci"},{"key":"9768_CR62","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1042\/BST0340600","volume":"34","author":"J Soule","year":"2006","unstructured":"Soule J, Messaoudi E, Bramham CR (2006) Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain. Biochem Soc Trans 34:600\u2013604. doi: 10.1042\/BST0340600","journal-title":"Biochem Soc Trans"},{"key":"9768_CR63","first-page":"109","volume":"53","author":"T Taketomi","year":"1983","unstructured":"Taketomi T, Kunishita T, Hara A, Mizushima S (1983) Abnormal protein and lipid compositions of the cerebral myelin of a patient with maple syrup urine disease. Jpn J Exp Med 53:109\u2013116","journal-title":"Jpn J Exp Med"},{"key":"9768_CR64","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-510X(00)00402-0","volume":"181","author":"RG Tavares","year":"2000","unstructured":"Tavares RG, Santos CE, Tasca CI, Wajner M, Souza DO, Dutra-Filho CS (2000) Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease. J Neurol Sci 181:44\u201349","journal-title":"J Neurol Sci"},{"key":"9768_CR65","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0169-328X(03)00030-5","volume":"111","author":"S Taylor","year":"2003","unstructured":"Taylor S, Srinivasan B, Wordinger RJ, Roque RS (2003) Glutamate stimulates neurotrophin expression in cultured Muller cells. Brain Res Mol Brain Res 111:189\u2013197","journal-title":"Brain Res Mol Brain Res"},{"key":"9768_CR66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01800354","volume":"15","author":"E Treacy","year":"1992","unstructured":"Treacy E, Clow CL, Reade TR, Chitayat D, Mamer OA, Scriver CR (1992) Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination. J Inherit Metab Dis 15:121\u2013135","journal-title":"J Inherit Metab Dis"},{"key":"9768_CR67","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0006-291X(83)90799-4","volume":"114","author":"D Tribble","year":"1983","unstructured":"Tribble D, Shapira R (1983) Myelin proteins: degradation in rat brain initiated by metabolites causative of maple syrup urine disease. Biochem Biophys Res Commun 114:440\u2013446","journal-title":"Biochem Biophys Res Commun"},{"key":"9768_CR68","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/1073858402238511","volume":"8","author":"WJ Tyler","year":"2002","unstructured":"Tyler WJ, Perrett SP, Pozzo-Miller LD (2002) The role of neurotrophins in neurotransmitter release. Neuroscientist 8:524\u2013531","journal-title":"Neuroscientist"},{"key":"9768_CR69","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jns.2004.12.015","volume":"232","author":"VC Vasques","year":"2005","unstructured":"Vasques VC, Brinco F, Wajner M (2005) Intrahippocampal administration of the branched-chain alpha-hydroxy acids accumulating in maple syrup urine disease compromises rat performance in aversive and non-aversive behavioral tasks. J Neurol Sci 232:11\u201321. doi: 10.1016\/j.jns.2004.12.015","journal-title":"J Neurol Sci"},{"key":"9768_CR70","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11068-007-9011-6","volume":"35","author":"C Verderio","year":"2006","unstructured":"Verderio C, Bianco F, Blanchard MP, Bergami M, Canossa M, Scarfone E, Matteoli M (2006) Cross talk between vestibular neurons and Schwann cells mediates BDNF release and neuronal regeneration. Brain Cell Biol 35:187\u2013201. doi: 10.1007\/s11068-007-9011-6","journal-title":"Brain Cell Biol"},{"key":"9768_CR71","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/glia.20969","volume":"58","author":"MW Vondran","year":"2010","unstructured":"Vondran MW, Clinton-Luke P, Honeywell JZ, Dreyfus CF (2010) BDNF+\/\u2212 mice exhibit deficits in oligodendrocyte lineage cells of the basal forebrain. Glia 58:848\u2013856. doi: 10.1002\/glia.20969","journal-title":"Glia"},{"key":"9768_CR72","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/adc.80.6.579","volume":"80","author":"M Wajner","year":"1999","unstructured":"Wajner M, Vargas CR (1999) Reduction of plasma concentrations of large neutral amino acids in patients with maple syrup urine disease during crises. Arch Dis Child 80:579","journal-title":"Arch Dis Child"},{"key":"9768_CR73","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1023\/A:1005668431926","volume":"23","author":"M Wajner","year":"2000","unstructured":"Wajner M, Coelho DM, Barschak AG, Araujo PR, Pires RF, Lulhier FL, Vargas CR (2000) Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises. J Inherit Metab Dis 23:505\u2013512","journal-title":"J Inherit Metab Dis"},{"key":"9768_CR74","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/13854040903527279","volume":"24","author":"KS Walsh","year":"2010","unstructured":"Walsh KS, Scott MN (2010) Neurocognitive profile in a case of maple syrup urine disease. Clin Neuropsychol 24:689\u2013700. doi: 10.1080\/13854040903527279","journal-title":"Clin Neuropsychol"},{"key":"9768_CR75","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1523\/JNEUROSCI.19-10-04155.1999","volume":"19","author":"GS Walsh","year":"1999","unstructured":"Walsh GS, Krol KM, Crutcher KA, Kawaja MD (1999) Enhanced neurotrophin-induced axon growth in myelinated portions of the CNS in mice lacking the p75 neurotrophin receptor. The J Neurosci Official J Soc Neurosci 19:4155\u20134168","journal-title":"The J Neurosci Official J Soc Neurosci"},{"key":"9768_CR76","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000323170","volume":"18","author":"J Xiao","year":"2010","unstructured":"Xiao J, Wong AW, Willingham MM, van den Buuse M, Kilpatrick TJ, Murray SS (2010) Brain-derived neurotrophic factor promotes central nervous system myelination via a direct effect upon oligodendrocytes. Neurosignals 18:186\u2013202. doi: 10.1159\/000323170","journal-title":"Neurosignals"},{"key":"9768_CR77","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/dneu.20765","volume":"70","author":"A Yoshii","year":"2010","unstructured":"Yoshii A, Constantine-Paton M (2010) Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev Neurobiol 70:304\u2013322. doi: 10.1002\/dneu.20765","journal-title":"Dev Neurobiol"},{"key":"9768_CR78","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000111436","volume":"18","author":"HR Zielke","year":"1996","unstructured":"Zielke HR, Huang Y, Tildon JT, Zielke CL, Baab PJ (1996) Elevation of amino acids in the interstitial space of the rat brain following infusion of large neutral amino and keto acids by microdialysis: alpha-ketoisocaproate infusion. Dev Neurosci 18:420\u2013425","journal-title":"Dev Neurosci"},{"key":"9768_CR79","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0197-0186(01)00077-8","volume":"40","author":"HR Zielke","year":"2002","unstructured":"Zielke HR, Zielke CL, Baab PJ, Collins RM (2002) Large neutral amino acids auto exchange when infused by microdialysis into the rat brain: implication for maple syrup urine disease and phenylketonuria. Neurochem Int 40:347\u2013354","journal-title":"Neurochem Int"},{"key":"9768_CR80","first-page":"385","volume":"26","author":"J Zou","year":"2006","unstructured":"Zou J, Crews F (2006) CREB and NF-kappaB transcription factors regulate sensitivity to excitotoxic and oxidative stress induced neuronal cell death. Cell Mol Neurobiol 26:385\u2013405. doi: 10.1007\/s10571-006-9045-9","journal-title":"Cell Mol Neurobiol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-015-9768-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-015-9768-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-015-9768-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T03:26:09Z","timestamp":1718421969000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-015-9768-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,20]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["9768"],"URL":"https:\/\/doi.org\/10.1007\/s11011-015-9768-8","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,20]]}}}